|
Aoki, N., Aoyama, K., Nagata, M. and Matsuda, T. (2001) A growing family of dual specificity phosphatases with low molecular masses. J. Biochem. (Tokyo) 130, 133–140 Adams, J., Williams, S. V., Aveyard, J. S. and Knowles, M. A. (2005) Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss. Cancer Res. 65, 66–75 Agarwal, R., Burley, S. K. and Swaminathan, S. (2008) Structure of human dual specificity protein phosphatase 23, VHZ, enzyme-substrate/product complex. J. Biol. Chem. 283, 8946–8953 Brondello, J. M., Brunet, A., Pouyssegur, J. and McKenzie, F. R. (1997) The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272, 1368–1376 Brondello, J. M., Pouyssegur, J. and McKenzie, F. R. (1999) Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286, 2514–2517 Brown, M. R., Chuaqui, R., Vocke, C. D., Berchuck, A., Middleton, L. P., mmert-Buck, M. R. and Kohn, E. C. (1999) Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors. Gynecol. Oncol. 74, 98–102 Biscardi JS, Maa M-C, Tice DA, Cox ME, Leu T-H, Parsons SJ. (1999). c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is ssociated with modulation of receptor function. J Biol Chem 274, 8335–8343 Burgess AW, Cho H-S, Eigenbrot C, Ferguson KM, Garrett TPJ, Leahy DJ et al. (2003). An Open-and-Shut Case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell 12, 541–552 Biscardi JS, Belsches AP, Parsons SJ. (1998) Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol Carcinog. 4, 261-72. Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ. (2000) Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res. Review. 3, 203-210. Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U. and Arkinstall, S. (1998) Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262–1265 Chen Y-R, Fu Y-N, Lin C-H, Yang S-T, Hu S-F, Chen Y-T et al. (2006). Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene 25, 1205–1215 Denu, J. M. and Dixon, J. E. (1998) Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr. Opin. Chem. Biol. 2, 633–641 Denu, J. M. and Dixon, J. E. (1995) A catalytic mechanism for the dual-specific phosphatases. Proc. Natl. Acad. Sci. U.S.A. 92, 5910–5914 Ekerot, M., Stavridis, M. P., Delavaine, L., Mitchell, M. P., Staples, C., Owens, D. M., Keenan, I. D., Dickinson, R. J., Storey, K. G. and Keyse, S. M. (2008) Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter. Biochem. J. 412, 287–298 Emmert-Buck, M. R., Vocke, C. D., Pozzatti, R. O., Duray, P. H., Jennings, S. B., Florence, C. D., Zhuang, Z., Bostwick, D. G., Liotta, L. A. and Linehan, W. M. (1995) Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res. 55, 2959–2962 Farooq, A. and Zhou, M. M. (2004) Structure and regulation of MAPK phosphatases. Cellular Signalling 16, 769-779 Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S. and Horii, A. (2003) Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 162, 1807–1815 Furukawa, T., Yatsuoka, T., Youssef, E. M., Abe, T., Yokoyama, T., Fukushige, S., Soeda, E., Hoshi, M., Hayashi, Y., Sunamura, M. et al. (1998) Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer. Cytogenet. Cell Genet. 82, 156–159 Fu, Y.-N., Yeh C.-L., Cheng, H. H.-Y., Yang, C.-H., Tsai, S.-F., Huang, S.-F., Chen, Y.-R. (2008) EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy. Oncogene, 27, 957-965 Geymonat, M., Jensen, S. and Johnston, L. H. (2002) Mitotic exit: the Cdc14 double cross. Curr. Biol. 12, R482–R484 Hoornaert, I., Marynen, P., Goris, J., Sciot, R. and Baens, M. (2003) MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation. Oncogene 22, 7728–7736 Huang S-F, Liu H-P, Li L-H, Ku Y-C, Fu Y-N, Tsai H-Y et al. (2004). High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancer related to gefitinib responsiveness in Taiwan. Clin Cancer Res 10, 8195–8203 Iliakis, G., Wang, Y., Guan, J. and Wang, H. (2003) DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22, 5834–5847 Ishibashi, T., Bottaro, D.P., Michieli, P., Kelley, C.A., Aaronson, S.A. (1992) Expression cloning of a human dual-specificity phosphatase. Biochem. J. 89, 12170– 12174 Ishizawar R, Parsons SJ. (2004). c-Src and cooperating partners in human cancer. Cancer Cell 6, 209–214 Keyse, S. M. (2000) Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12, 186–192 Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. and Karin, M. (2005) Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649–661 Katagiri, C., Masuda, K., Urano, T., Yamashita, K., Araki, Y., Kikuchi, K. and Shima, H. (2005) Phosphorylation of Ser-446 determines stability of MKP-7. J. Biol. Chem. 280, 14716–14722 Liao, Q., Guo, J., Kleeff, J., Zimmermann, A., Buchler, M. W., Korc, M. and Friess, H. (2003) Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology 124, 1830–1845 Marti, F., Krause, A., Post, N.H., Lyddane, C., Dupont, B., Sadelain, M., King, P.D. (2001) Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. Immunol. J. 166, 197– 206 Stewart, A. E., Dowd, S., Keyse, S. M. and McDonald, N. Q. (1999) Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation. Nat. Struct. Biol. 6, 174–181 Schullerus, D., Herbers, J., Chudek, J., Kanamaru, H. and Kovacs, G. (1997) Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J. Pathol. 183, 151–155 Stamos J, Sliwkowski MX, Eigenbrot C. (2002). Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 277, 46265–46272 Tonks, N. K. and Neel, B. G. (2001) Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13, 182–195 Takagaki, K., Satoh, T., Tanuma, N., Masuda, K., Takekawa, M., Shima, H. and Kikuchi, K. (2004) Characterization of a novel low-molecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38. Biochem. J. 383, 447–455 Wu, Q., Huang, S., Sun, Y., Gu, S., Lu, F., Dai, J., Yin, G., Sun, L., Zheng, D., Dou, C. et al. (2006) Dual specificity phosphotase 18, interacting with SAPK, dephosphorylates SAPK and inhibits SAPK/JNK signal pathway in vivo. Front. Biosci. 11, 2714–2724 Wu, Q., Li, Y., Gu, S., Li, N., Zheng, D., Li, D., Zheng, Z., Ji, C., Xie, Y. and Mao, Y. (2004) Molecular cloning and characterization of a novel dual-specificity phosphatase 23 gene from human fetal brain. Int. J. Biochem. Cell Biol. 36, 1542–1553 Xu, S., Furukawa, T., Kanai, N., Sunamura, M. and Horii, A. (2005) Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. J. Hum. Genet. 50, 159–167
|